Skip to Main Content

Paper Details

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.
Sci Immunol
10
2023
CD103PD, CD103PD-1CD8, CD8, CD8 T cells, CTX, CTX TILs, CTXCD8 TILs, HNSCC, PD-1, TILs, TME, anti-PD-1, antitumor T cells, head and neck cancer, head and neck squamous cell carcinoma, nonexhausted persisting clones, patients, tumor, tumor-resident T cells, tumor-specific exhausted CD8 tumor-infiltrating lymphocytes, tumors
Author NameAffiliation
Ann Marie EgloffDana-Farber Cancer Institute
Ann Marie EgloffBrigham and Women's Hospital
Ann Marie EgloffHarvard Medical School
Ann Marie EgloffDana-Farber Cancer Institute
Ann Marie EgloffHarvard Medical School
Ann Marie EgloffBrigham and Women's Hospital
Luc G T MorrisMemorial Sloan Kettering Cancer Center
Catherine J WuDana-Farber Cancer Institute
Catherine J WuBrigham and Women's Hospital
Catherine J WuBroad Institute of MIT and Harvard
Catherine J WuHarvard Medical School
Ravindra UppaluriDana-Farber Cancer Institute
Ravindra UppaluriHarvard Medical School
Ravindra UppaluriBrigham and Women's Hospital
  • 1 - 14

Datasets

Release 1.2